tokens: The incidence rates of events were determined in all patients ( n = 7934 ) and in users of low - dose (< or = 325 mg daily ) aspirin ( n = 1051 ) and nonusers of aspirin ( n = 6883 ). Crude and exposure - adjusted incidences of thrombotic events were similar for valdecoxib , NSAIDs , and placebo .